|
|
|
1 | (14) |
|
|
|
2 Evidence Based Medicine: Quality of Evidence and Evaluation Systems |
|
|
15 | (14) |
|
|
|
|
|
3 Decision Analytic Techniques and Other Decision Processes |
|
|
29 | (12) |
|
|
|
|
|
4 Decision Making: The Surgeon's Perspective |
|
|
41 | (12) |
|
|
|
5 Involving Patients in Difficult Decisions About Having Surgery |
|
|
53 | (14) |
|
|
|
|
|
|
|
|
|
|
6 EBUS vs. Mediastinoscopy for Initial Pathologic Mediastinal Staging in NSCLC |
|
|
67 | (16) |
|
|
|
|
|
7 Does Preoperative Smoking Cessation Reduce Surgical Morbidity After Lung Resection? |
|
|
83 | (12) |
|
|
|
|
|
8 Is Low Tech as Good as High Tech Exercise Testing in Assessing Healthy Candidates for Lung Resection? |
|
|
95 | (8) |
|
|
|
|
|
9 Does Assessment of Frailty and Sarcopenia in Lung Resection Candidates Affect Patient Selection? |
|
|
103 | (24) |
|
|
|
|
|
10 Can Frailty and Sarcopenia Be Mitigated in Lung Resection Candidates? |
|
|
127 | (10) |
|
|
|
11 Is Antibiotic Prophylaxis Necessary for Major Lung Resection? |
|
|
137 | (8) |
|
|
|
|
|
12 Uniportal Versus Multiportal VATS Lobectomy |
|
|
145 | (12) |
|
|
|
13 Robotic Versus Video-Assisted Thoracoscopic Surgery (VATS) Major Lung Resection for Early Stage NSCLC |
|
|
157 | (10) |
|
|
|
|
|
14 Does Blood Patch for Persistent Postoperative Air Leak Reduce Air Leak Duration |
|
|
167 | (10) |
|
|
|
|
|
15 Is Resection of Persistent N2 Disease After Induction Therapy Effective? |
|
|
177 | (16) |
|
|
|
16 N2 Disease Discovered at the Time of Vats Lung Resection: Resect or Abort? |
|
|
193 | (12) |
|
|
|
|
|
|
|
17 Does Induction Immunotherapy Confer Increased Operative Risk for Lung Resection? |
|
|
205 | (10) |
|
|
|
|
|
|
|
18 Does an Enhanced Recovery Program for Lobectomy Improve Surgical Outcomes? |
|
|
215 | (10) |
|
|
|
|
|
19 Resection vs. SBRT for Stage I NSCLC in Patients with Good Pulmonary Function |
|
|
225 | (12) |
|
|
|
|
|
20 Do Endobronchial Valves Assist in Resolution of Postoperative Persistent Air Leak? |
|
|
237 | (10) |
|
|
|
|
|
21 Is Long-Term Surveillance Effective After Resection of Stage I Non-small Cell Lung Cancer? |
|
|
247 | (10) |
|
|
|
|
|
22 Does ECMO for Lung Failure in ICU Patients Improve Survival? |
|
|
257 | (10) |
|
|
|
|
|
23 Does Local Therapy for Oligometastatic Disease in Lung Cancer Patients Improve Survival? |
|
|
267 | (12) |
|
|
|
24 Is Pulmonary Metastasectomy Effective in Prolonging Survival? |
|
|
279 | (14) |
|
|
|
|
|
|
|
|
25 Surgical Resection Versus Endoscopic Therapy for T1bN0 Esophageal Adenocarcinoma |
|
|
293 | (12) |
|
|
|
|
|
26 Does Induction Therapy for T2N0 Esophageal Adenocarcinoma Patients Improve Survival? |
|
|
305 | (12) |
|
|
|
|
|
27 Can Frailty and Sarcopenia Be Mitigated in Esophagectomy Candidates? |
|
|
317 | (14) |
|
|
|
|
|
28 Do Enhanced Recovery Programs for Esophagectomy Patients Improve Outcomes? |
|
|
331 | (12) |
|
|
|
|
|
29 Does Jejunostomy Tube Feeding Improve Outcomes After Esophagectomy? |
|
|
343 | (12) |
|
|
|
|
|
Richard van Hillegersberg |
|
|
30 Surgery Versus Definitive Chemoradiotherapy for Regionally Advanced Esophageal Squamous Cell Cancer |
|
|
355 | (6) |
|
|
|
31 Robotic Minimally Invasive Esophagectomy (RAMIE) vs. Open Esophagectomy (OE) for Resectable Esophageal Cancer |
|
|
361 | (8) |
|
|
|
|
|
|
|
32 Two-Field vs. Three-Field Lymphadenectomy for Esophageal Adenocarcinoma |
|
|
369 | (8) |
|
|
|
|
|
33 What Is the Appropriate Extent of Lymph Node Dissection in Esophageal Cancer |
|
|
377 | (10) |
|
|
|
|
|
34 Salvage Esophagectomy for Persistent or Recurrent Disease After Chemoradiation |
|
|
387 | (14) |
|
|
|
|
|
|
|
35 Early Oral Feeding After Esophagectomy |
|
|
401 | (12) |
|
|
|
|
|
|
|
36 Stent vs. Primary Repair for Esophageal Perforation |
|
|
413 | (8) |
|
|
|
|
|
37 Endoluminal Vacuum Therapy vs. Stenting for Esophageal Anastomotic Leaks |
|
|
421 | (12) |
|
|
|
|
|
38 Thoracoscopic Versus Endoscopic Therapy for Small Sub-epithelial Esophageal Tumors |
|
|
433 | (12) |
|
|
|
|
|
|
|
39 Laparoscopic vs. Endoscopic Therapy for Achalasia |
|
|
445 | (10) |
|
|
|
|
|
40 Laparoscopy or Endoscopic Therapy for Recurrent Symptoms from Achalasia |
|
|
455 | (12) |
|
|
|
|
|
|
|
41 Laparoscopy or Thoracotomy for Symptomatic Recurrent Paraesophageal Hernia |
|
|
467 | (8) |
|
|
|
|
|
|
|
|
42 Does Diaphragm Pacing for Bilateral Phrenic Nerve Paralysis Improve Function or Quality of Life? |
|
|
475 | (12) |
|
|
|
43 Does Phrenic Nerve Reconstruction for Unilateral Diaphragm Paralysis Improve Function or Quality of Life |
|
|
487 | (8) |
|
|
|
|
|
44 Is Plication for Diaphragmatic Eventration Effective in Improving Lung Function? |
|
|
495 | (10) |
|
|
|
|
|
|
|
|
45 Is Long-Term Stenting for Benign Airway Obstruction Effective? |
|
|
505 | (8) |
|
|
|
|
|
46 Are Engineered Tissues Useful for Tracheal Reconstruction? |
|
|
513 | (10) |
|
|
|
|
|
47 Management of Positive Margins After Resection of Primary Tracheal Malignancies |
|
|
523 | (10) |
|
|
|
|
|
48 Optimal Management of Posttransplant Bronchial Stenosis: Stenting or Reoperation |
|
|
533 | (14) |
|
|
|
|
|
Part V Pleura and Pleural Spaces |
|
|
|
49 Is tPA/DNase Effective in the Management of Pleural Empyema? |
|
|
547 | (6) |
|
|
|
|
|
50 VATS vs Open Management of Pleural Empyema |
|
|
553 | (8) |
|
|
|
51 Indwelling Pleural Catheters Versus Talc Pleurodesis for Recurrent Symptomatic Malignant Pleural Effusions |
|
|
561 | (10) |
|
|
|
|
|
|
|
52 Quality of Life: Extended Pleurectomy/Decortication vs Extrapleural Pneumonectomy |
|
|
571 | (12) |
|
|
|
|
|
|
|
|
53 Does Thymectomy Improve Outcomes in Patients with Nonthymomatous Myasthenia Gravis? |
|
|
583 | (8) |
|
|
|
|
|
54 Magnetic Resonance Imaging for Evaluation of Suspected Encapsulated Thymoma |
|
|
591 | (6) |
|
|
|
|
|
55 Robotic vs. Thoracoscopic Thymectomy for Thymoma |
|
|
597 | (8) |
|
|
|
56 VATS for Resection of Mediastinal Parathyroid Adenomas |
|
|
605 | (8) |
|
|
|
|
|
57 Thymectomy in the Setting of Pleural Metastasis |
|
|
613 | (16) |
|
|
|
|
|
58 Sympathectomy for Malignant Ventricular Arrhythmias |
|
|
629 | (6) |
|
|
|
|
|
59 The Extent of Surgery for Palmar Hyperhidrosis |
|
|
635 | (10) |
|
|
|
|
|
|
|
|
60 Synthetic Versus Biologic Reconstruction of Bony Chest Wall Defects |
|
|
645 | (10) |
|
|
|
|
|
61 Traumatic Rib Fracture in the Absence of Flail Chest: Conservative Therapy or Surgical Fixation? |
|
|
655 | (8) |
|
|
|
|
|
62 Is Surgical Management of Flail Chest Effective? |
|
|
663 | (8) |
|
|
|
|
|
63 Epidural vs Regional Blocks for VATS and Thoracotomy |
|
|
671 | (14) |
|
|
|
|
|
64 The Nuss Procedure Versus the Modified Ravitch Repair for Pectus Excavatum in Adults |
|
|
685 | (6) |
|
|
| Index |
|
691 | |
Biežāk uzdotie jautājumi par e-grāmatām